Michael Palmer

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

Paul E. Goss, James N. Ingle, Silvana Martino et al. · JNCI Journal of the National Cancer Institute · 2005 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +12

Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols

Melanie Calvert, Derek Kyte, Rebecca Mercieca‐Bebber et al. · JAMA · 2018 · 798 citations · Full text

Pharmacy, Health Policy, Evidence-based Practice +16

Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With <i>EGFR</i> Mutations

James Chih‐Hsin Yang, Vera Hirsh, Martin Schüler et al. · Journal of Clinical Oncology · 2013 · 321 citations

Medicine, Oncology, Pharmacology +16

A Randomized Trial of Letrozole in Postmenopausal Women After Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

Paul E. Goss, James N. Ingle, Silvana Martino et al. · Obstetrical & Gynecological Survey · 2004 · 314 citations

Pharmacy, Endocrinology, Oncology +14

Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17

Edith A. Perez, Robert G. Josse, Kathleen I. Pritchard et al. · Journal of Clinical Oncology · 2006 · 305 citations · Full text

Medicine, Oncology, Pharmacotherapy +17